Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Hep C Discussion Forum -> Hep C News -> NICE (UK) releases final guidance for access to Harvoni, Viekirax and Daklinza hepatitis C treatments
Post Info TOPIC: NICE (UK) releases final guidance for access to Harvoni, Viekirax and Daklinza hepatitis C treatments
Cinnamon Girl


Guru

Status: Offline
Posts: 5629
Date:
NICE (UK) releases final guidance for access to Harvoni, Viekirax and Daklinza hepatitis C treatments
Permalink  
 

Following the release last month of provisional recommendations, the National Institute for Health and Care Excellence (NICE) has now published final guidance recommending Harvoni, Viekirax (with or without Exviera) and Daklinza for treatment of people with certain genotypes of hep C.

The NICE guidance documents released today will mean significantly wider access to the new non-interferon, direct acting anti-viral treatments for hepatitis C, which have shorter treatment regimes and less severe side effects for patients than previous interferon-based therapies.

The guidance means that those with hep C genotypes 1 or 4 should have treatment made available to them on the NHS within three months of guidance being issued (today, 25th November 2015).

 

Full details...

http://www.hepctrust.org.uk/news/nov-2015/nice-releases-final-guidance-access-harvoni-viekirax-and-daklinza-hepatitis-c



__________________

Jill 

(71 yo, lives in UK)

Was Gen 3a, 

24wks Peg Ifn/Riba, Sep 2010 - Mch 2011

UND @ Wk.4, UND @ EOT, 

SVR Nov 2011 --> Still UND @ EOT + 4 yrs.

 

 
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.
Hep C Discussion Forum -> Hep C News -> NICE (UK) releases final guidance for access to Harvoni, Viekirax and Daklinza hepatitis C treatments
Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.